Total Payments
$16,336
2024 Payments
$288.50
Companies
9
Transactions
28
Medicare Patients
335
Medicare Billing
$87,154
Payment Breakdown by Category
Consulting$10,460 (64.0%)
Other$2,925 (17.9%)
Food & Beverage$2,154 (13.2%)
Travel$796.23 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,460 | 2 | 64.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,925 | 1 | 17.9% |
| Food and Beverage | $2,154 | 24 | 13.2% |
| Travel and Lodging | $796.23 | 1 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $12,193 | 8 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $2,637 | 4 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $465.89 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $322.93 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $223.44 | 2 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $166.80 | 2 | $0 (2022) |
| Allergan Inc. | $139.21 | 1 | $0 (2018) |
| ITI, Inc. | $93.85 | 1 | $0 (2021) |
| Tris Pharma Inc | $93.82 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.50 | 3 | Teva Pharmaceuticals USA, Inc. ($121.82) |
| 2023 | $248.67 | 3 | Teva Pharmaceuticals USA, Inc. ($121.82) |
| 2022 | $2,772 | 7 | Sunovion Pharmaceuticals Inc. ($2,637) |
| 2021 | $93.85 | 1 | ITI, Inc. ($93.85) |
| 2020 | $2,925 | 1 | Alkermes, Inc. ($2,925) |
| 2019 | $380.45 | 4 | Teva Pharmaceuticals USA, Inc. ($116.99) |
| 2018 | $477.01 | 4 | Neurocrine Biosciences, Inc. ($201.16) |
| 2017 | $9,151 | 5 | Alkermes, Inc. ($9,076) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $117.53 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $49.15 | General |
| Category: Neuropsychiatry | ||||||
| 02/01/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Neurology | ||||||
| 06/14/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $97.15 | General |
| Category: CNS | ||||||
| 04/19/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Central Nervous System | ||||||
| 03/03/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Neuropsychiatry | ||||||
| 11/09/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $92.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2022 | Sunovion Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $2,460.00 | General |
| 11/02/2022 | Sunovion Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $104.64 | General |
| 11/02/2022 | Sunovion Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $56.40 | General |
| 09/09/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neuropsychiatry | ||||||
| 07/11/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Neuropsychiatry | ||||||
| 04/08/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: CNS | ||||||
| 12/08/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $93.85 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2020 | Alkermes, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| 11/09/2019 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $93.82 | General |
| Category: ADHD | ||||||
| 10/28/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $105.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $116.99 | General |
| Category: Central Nervous System | ||||||
| 10/02/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $63.73 | General |
| Category: CNS | ||||||
| 12/14/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $105.26 | General |
| Category: Central Nervous System | ||||||
| 11/15/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $139.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: CNS | ||||||
| 05/07/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $201.16 | General |
| Category: NEUROLOGY | ||||||
| 06/05/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| Category: CNS | ||||||
| 05/21/2017 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $74.71 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 131 | 442 | $157,811 | $32,019 |
| 2022 | 3 | 55 | 254 | $90,542 | $16,365 |
| 2021 | 5 | 90 | 328 | $121,678 | $24,172 |
| 2020 | 3 | 59 | 247 | $97,472 | $14,598 |
Total Patients
335
Total Services
1,271
Medicare Billing
$87,154
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 94 | $58,196 | $10,856 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 58 | $40,732 | $10,004 | 24.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 37 | 121 | $40,490 | $7,433 | 18.4% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 39 | 169 | $18,393 | $3,727 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 82 | $58,492 | $9,276 | 15.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 18 | 86 | $27,494 | $5,216 | 19.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 19 | 86 | $4,556 | $1,873 | 41.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 80 | $56,960 | $9,495 | 16.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 21 | 78 | $23,712 | $4,519 | 19.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 43 | $15,824 | $4,105 | 25.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 22 | $19,932 | $3,783 | 19.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 23 | 105 | $5,250 | $2,270 | 43.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 87 | $65,779 | $7,965 | 12.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 20 | 93 | $28,343 | $5,210 | 18.4% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 19 | 67 | $3,350 | $1,424 | 42.5% |
About Dr. Rona Hu, MD
Dr. Rona Hu, MD is a Psychiatry healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508991597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rona Hu, MD has received a total of $16,336 in payments from pharmaceutical and medical device companies, with $288.50 received in 2024. These payments were reported across 28 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($10,460).
As a Medicare-enrolled provider, Hu has provided services to 335 Medicare beneficiaries, totaling 1,271 services with total Medicare billing of $87,154. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Palo Alto, CA
- Active Since 02/22/2007
- Last Updated 04/30/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1508991597
Products in Payments
- Aristada 441 mg (Drug) $9,107
- AUSTEDO (Drug) $344.07
- INGREZZA (Drug) $322.93
- REXULTI (Drug) $223.44
- VRAYLAR (Drug) $139.21
- UZEDY (Drug) $121.82
- LYBALVI (Drug) $97.15
- CAPLYTA (Drug) $93.85
- Dyanavel XR (Drug) $93.82
- ABILIFY MAINTENA (Drug) $92.09
- ARISTADA (Drug) $63.73
- LATUDA (Drug) $15.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Palo Alto
Dr. Julie Bonner, M.d, M.D
Psychiatry — Payments: $341,990
Psychiatry $341,990
Jacob Ballon, Md, MD
Psychiatry — Payments: $53,818
Psychiatry $53,818
Dr. David Spiegel, M.d, M.D
Psychiatry — Payments: $40,937
Psychiatry $40,937
Charles Debattista, Md, MD
Psychiatry — Payments: $35,632
Psychiatry $35,632
Neir Eshel, Md, MD
Psychiatry — Payments: $20,083
Psychiatry $20,083
Dr. Jack Turban, Md, MD
Psychiatry — Payments: $15,000
Psychiatry $15,000